Sonnet BioTherapeutics Holdings, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of SONN for the last quarter is 18.63 k USD, and it's 50.00% lower compared to the previous quarter. The net income of Q1 24 is -1.17 M USD.